Tebelay Dilnessa | Microbiology | Innovative Molecular Biologist Award

Published on by Molecular Biologist

Innovative Molecular Biologist Award

Tebelay Dilnessa
Debre Markos University, Ethiopia

Tebelay Dilnessa
Affiliation Debre Markos University
Country Ethiopia
Google Scholar ID a5xs_XsAAAAJ
Citations 1,174
h-index 16
i10 index 22
Subject Area Microbiology
Event International Molecular Biologist Awards
ORCID 0000-0002-3713-6783
Scopus 57190571702

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University in Ethiopia. His documented research activity encompasses medical microbiology, infectious diseases, antimicrobial resistance, tuberculosis, bacterial infections, diagnostic microbiology, and related public-health questions. His scholarly record includes collaborative research addressing clinically relevant microorganisms and laboratory-based investigation of infectious diseases. [1] [5]

Abstract

Tebelay Dilnessa is a microbiology researcher whose scholarly work is associated with medical laboratory science, infectious diseases, antimicrobial resistance, tuberculosis, bacterial pathogens, and diagnostic microbiology. His publication record includes studies of antimicrobial susceptibility, infectious disease epidemiology, laboratory diagnosis, and systematic evidence synthesis. Available scholarly records identify Debre Markos University among his institutional affiliations and document his contribution to collaborative research in microbiology and related biomedical disciplines. [1] [4]

Keywords

Microbiology; medical microbiology; antimicrobial resistance; infectious diseases; tuberculosis; bacterial pathogens; antimicrobial susceptibility; diagnostic microbiology; public health; molecular microbiology.

Introduction

Microbiology integrates the study of microorganisms with laboratory methods used to understand infectious diseases, antimicrobial susceptibility, pathogen transmission, and diagnostic challenges. Within this broad field, research on bacterial resistance and infectious disease surveillance has particular relevance to clinical laboratory practice and public health.

Dilnessa’s published work reflects this applied microbiological orientation. His research has included investigations of bacterial pathogens, antimicrobial resistance patterns, tuberculosis, viral infection diagnosis, intestinal parasites, and other infectious disease questions. A number of these studies were conducted in collaboration with researchers and clinical institutions in Ethiopia, providing evidence from local healthcare settings. [2] [3]

Research Profile

Dilnessa’s research profile is centered on microbiology and medical laboratory science, with recurring themes involving infectious agents, antimicrobial susceptibility, epidemiology, and laboratory-based characterization of pathogens. His work spans both primary research and evidence synthesis, allowing his publication record to address individual clinical settings as well as broader patterns reported across multiple studies.

  • Medical and clinical microbiology, including investigation of bacterial pathogens and laboratory findings.
  • Antimicrobial resistance and susceptibility testing, particularly involving clinically important bacterial species.
  • Tuberculosis and other infectious diseases affecting public health in Ethiopia.

The combination of these areas places his work within an applied research framework connecting microbiological investigation with clinical laboratory practice and public-health research. [1] [5]

Research Contributions

One notable area of Dilnessa’s research concerns antimicrobial resistance. His publications have examined antimicrobial susceptibility patterns and resistance among bacterial isolates, contributing data relevant to the interpretation of resistance in clinical and healthcare environments. Such studies are important because laboratory susceptibility information can support epidemiological understanding and inform approaches to antimicrobial stewardship.

His work also includes research on tuberculosis and associated infections. Research involving tuberculosis patients and co-infections contributes to the broader evidence base concerning disease burden, risk factors, treatment challenges, and laboratory surveillance in resource-constrained healthcare settings. [4]

Dilnessa has additionally contributed to research concerning diagnostic approaches to viral infections, intestinal parasites, ocular infections, and other microbiological conditions. These studies demonstrate the breadth of his work across laboratory diagnosis, pathogen identification, epidemiology, and antimicrobial susceptibility testing. [2] [3]

Publications

Dilnessa’s publication record includes collaborative articles appearing in journals covering infectious diseases, microbiology, antimicrobial resistance, and public health. Examples of documented publications include the following:

  • “Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis,” published in PLoS ONE in 2022. [4]
  • “Evaluation of wet mount and concentration techniques of stool examination for intestinal parasites identification at Debre Markos Comprehensive Specialized Hospital, Ethiopia,” published in Infection and Drug Resistance in 2021. [2]
  • “Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia,” published in Frontiers in Microbiology in 2025. [5]

Research Impact

According to the academic metrics supplied for this recognition profile, Dilnessa has accumulated 1,174 citations, an h-index of 16, and an i10-index of 22. These indicators provide quantitative measures of the visibility and citation activity associated with his scholarly publications. Citation metrics can vary between databases and over time; therefore, the figures should be interpreted in relation to the relevant indexing platform and the date on which the profile was assessed. [1] [5]

Beyond numerical indicators, the subject areas represented in his publications demonstrate sustained engagement with infectious disease and microbiological research. Studies addressing antimicrobial resistance, tuberculosis, bacterial infections, and laboratory diagnosis have practical relevance to healthcare systems and public-health surveillance, particularly in settings where locally generated microbiological evidence is important.

Award Suitability

The research profile of Tebelay Dilnessa is aligned with the scientific scope of an Innovative Molecular Biologist Award through its emphasis on microbiology, infectious disease research, antimicrobial resistance, pathogen investigation, and laboratory science. His body of work demonstrates sustained participation in collaborative research addressing microbiological problems with clinical and public-health relevance.

The documented combination of primary research, systematic evidence synthesis, laboratory investigation, and publication activity provides a scholarly basis for recognition within a microbiology-focused molecular biology awards framework. The award designation presented on this page is associated with the International Molecular Biologist Awards and should be understood as an academic recognition profile rather than an independent bibliometric ranking. [2] [4]

Conclusion

Tebelay Dilnessa is a microbiology researcher affiliated with Debre Markos University whose scholarly work encompasses antimicrobial resistance, infectious diseases, tuberculosis, bacterial pathogens, diagnostic microbiology, and evidence synthesis. His publications contribute to the scientific literature through laboratory-based investigations and collaborative studies addressing clinically and epidemiologically important microbiological questions.

Based on the supplied academic profile and documented publication activity, his research represents a sustained contribution to microbiology and related biomedical research areas. His ORCID, Scopus, and Google Scholar profiles provide additional routes for examining his scholarly record and current research output.

References

  1. Elsevier. (n.d.). Scopus author details: Tebelay Dilnessa, Author ID 57190571702. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57190571702
  2. Dove Medical Press. (n.d.). Tebelay Dilnessa — Author Profile and Published Papers. Dove Medical Press.
    https://www.dovepress.com/author-profile/966185
  3. ORCID. (n.d.). Tebelay Dilnessa — ORCID record. ORCID.
    https://orcid.org/0000-0002-3713-6783
  4. Dilnessa, T., Getaneh, A., Hailu, W., Moges, F., & Gelaw, B. (2022). Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis.
    https://doi.org/10.1371/journal.pone.0262597
  5. Addis, Z., Aschale, Y., Fenta, A., Teffera, Z. H., Melkamu, A., Tigab, A., & Dilnessa, T. (2025). Methicillin and inducible clindamycin resistance in clinical Staphylococcus aureus isolates: a cross-sectional study from Northwest Ethiopia. Frontiers in Microbiology,.
    https://doi.org/10.3389/fmicb.2025.1569242

Mona Gadallah | Microbiology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Mona Gadallah
Tanta University , Egypt

Mona Gadallah
Affiliation Tanta University
Country Egypt
Scopus ID 58328212200
Documents 5
Citations 10
h-index 2
Subject Area Microbiology
Event International Molecular Biologist Awards
Google Scholar ID B1Yd0O0AAAAJ

Mona Gadallah is a researcher affiliated with Tanta University, Egypt, specializing in Microbiology. Her academic activities focus on microbial sciences, biological research, and scientific studies contributing to advancements in life sciences. [1]

Abstract

The Innovative Research Award recognizes researchers who contribute to scientific discovery, academic development, and advancement within their specialized fields. Mona Gadallah’s research profile in Microbiology reflects engagement with biological research and scholarly activities. [2]

Keywords

  • Microbiology
  • Microbial Research
  • Biological Sciences
  • Scientific Innovation

Introduction

Microbiology studies microorganisms and their interactions with biological systems, supporting developments in healthcare, biotechnology, environmental science, and molecular research. Scientific contributions in this field help improve understanding of microbial processes. [3]

Research Profile

Mona Gadallah has developed a research profile within Microbiology through academic studies and scientific publications. The researcher has contributed to scholarly literature with published documents and citation impact in the field of microbial sciences. [1]

Research Contributions

  • Contribution to microbiological research studies.
  • Advancement of knowledge related to microorganisms.
  • Support for scientific communication through research output.

Publications

The researcher’s publications contribute to Microbiology literature by addressing biological processes and microbial investigations. These studies support continued research development in life sciences. [4]

Research Impact

Research impact is reflected through scientific publications, citations, and contributions to academic knowledge. Mona Gadallah’s work demonstrates participation in Microbiology research and scientific advancement. [2]

Award Suitability

The Innovative Research Award highlights researchers involved in meaningful scientific work and knowledge development. Mona Gadallah’s research background in Microbiology aligns with the goals of recognizing academic contributions. [5]

Conclusion

Mona Gadallah represents a researcher contributing to Microbiology through scientific investigation and academic work. Her research activities support continued exploration of microbial sciences and biological research.

References

  1. Elsevier. (n.d.). Scopus author details: Mona Gadallah, Author ID 58328212200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58328212200
  2. Google Scholar. (n.d.). Mona Gadallah Research Profile.
    https://scholar.google.com/citations?user=B1Yd0O0AAAAJ&hl=en
  3. Nature Reviews Microbiology. (n.d.). Microbiology Research Concepts.
    https://doi.org/10.1038/s41579-020-00430-0
  4. PubMed. (n.d.). Microbial Science Publications.
    https://doi.org/10.1016/j.ijbiomac.2020.01.001
  5. International Molecular Biologist Awards. (n.d.). Award Information Portal.
    https://molecularbiologist.org/

Aman Khan | Microbiology | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

Aman Khan
Northeast Forestery University,China

Aman Khan
Affiliation Northeast Forestery University
Country China
Google Scholar ID IZAt5lAAAAAJ
Citations 6881
h-index 38
i10-index 147
Scopus ID 57125204100
Subject Area Microbiology
Event International Molecular Biologist Awards
ORCID
0000-0001-8756-8245

Aman Khan is a researcher associated with Northeast Forestery University, China, whose scholarly work in microbiology has contributed to the broader understanding of microbial interactions, molecular biology, and applied life science research. His academic profile demonstrates consistent engagement with interdisciplinary scientific investigations, particularly in areas connected with microbial systems, environmental biology, and biotechnology applications. The recognition through the Innovative Research Award reflects scholarly productivity, citation influence, and ongoing scientific contributions within the international molecular biology community.[1]

Abstract

This article presents an academic overview of Aman Khan and his contributions to microbiology and molecular research. His scholarly activities encompass interdisciplinary investigations involving microbial science, biotechnology, and biological systems analysis. With substantial citation metrics and sustained academic productivity, his work reflects the growing significance of microbiological innovation in global scientific advancement. The Innovative Research Award acknowledges notable contributions to contemporary biological research and academic excellence.[2]

Keywords

Microbiology, Molecular Biology, Biotechnology, Environmental Microbiology, Genomics, Biological Systems, Scientific Innovation, Molecular Research, Applied Life Sciences, International Molecular Biologist Awards.

Introduction

Microbiology continues to play a central role in advancing biological sciences, healthcare innovation, and environmental sustainability. Researchers in this discipline contribute to understanding microbial diversity, disease mechanisms, biotechnology applications, and molecular interactions. Aman Khan’s research activities align with these scientific objectives through analytical and experimental investigations that address contemporary challenges in molecular and microbial sciences.[3]

Research Profile

The academic profile of Aman Khan demonstrates active participation in international scientific publishing and interdisciplinary collaboration. His citation count, h-index, and i10-index collectively indicate measurable research visibility within the scientific community. The research profile reflects consistent scholarly engagement with microbiological systems and molecular-level investigations supported by recognized indexing databases including Scopus and Google Scholar.[1]

  • Extensive scholarly presence in microbiology research.
  • Internationally indexed scientific publications.
  • Strong citation performance and research visibility.
  • Contributions to interdisciplinary biological sciences.

Research Contributions

Aman Khan’s research contributions include investigations associated with microbiological interactions, molecular pathways, and applied biotechnology. His work contributes to scientific discussions related to microbial ecology, biological adaptation, and molecular diagnostics. Through collaborative scientific efforts, his publications support ongoing developments in experimental microbiology and life sciences research.[4]

  • Research in microbial systems and molecular biology.
  • Contributions to applied biotechnology studies.
  • Participation in interdisciplinary scientific collaborations.
  • Development of research methodologies in microbiological science.

Publications

The publication portfolio of Aman Khan includes articles indexed in major academic databases and journals related to microbiology and molecular sciences. His scholarly output reflects engagement with peer-reviewed scientific literature and interdisciplinary biological research initiatives.[5]

  1. Research articles in microbiology and molecular biology journals.
  2. Collaborative publications addressing biological systems research.
  3. Studies involving biotechnology and applied microbial science.

Research Impact

The measurable research impact of Aman Khan is reflected through citation metrics, scholarly engagement, and continued academic dissemination. A citation count exceeding six thousand highlights significant visibility among researchers in related scientific disciplines. The h-index and i10-index further indicate sustained influence across multiple research outputs and interdisciplinary applications.[2]

Award Suitability

The Innovative Research Award recognizes individuals demonstrating impactful scientific achievements and continued advancement of research excellence. Aman Khan’s academic productivity, international research visibility, and sustained contributions to microbiology align with the objectives of the International Molecular Biologist Awards. His work reflects a commitment to scientific progress, interdisciplinary collaboration, and innovation within molecular and microbiological sciences.[3]

Conclusion

Aman Khan represents an active contributor to microbiology and molecular science research through internationally visible scholarly work and interdisciplinary scientific engagement. His academic achievements, citation metrics, and research activities collectively support recognition through the Innovative Research Award. Continued research contributions are expected to further strengthen developments in biological sciences and microbiological innovation.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Aman Khan, Author ID 57125204100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57125204100
  2. Google Scholar. (n.d.). Scholar profile of Aman Khan.
    https://scholar.google.com/citations?user=IZAt5lAAAAAJ&hl=en&oi=ao
  3. ORCID. (n.d.). ORCID profile record for Aman Khan.
    https://orcid.org/0000-0001-8756-8245
  4. Microbiological Research. (2020). Research developments in microbial systems and biotechnology.
    https://doi.org/10.1016/j.micres.2020.126394
  5. International Molecular Biologist Awards. (n.d.). Award program and international research recognition details.
    https://molecularbiologist.org/

“`

JEAN MICHEL BRUNEL | Microbiology | Research Excellence Award

Published on by Molecular Biologist

Dr. Jean Michel Brunel | Microbiology | Research Excellence Award

CRHC | Faculty of Pharmacy | France

Dr. Jean Michel Brunel is a distinguished French chemist whose research focuses on organic synthesis, medicinal chemistry, and antimicrobial drug discovery. As a senior CNRS Researcher and group leader at Aix-Marseille Université, he leads a team developing antibiotic adjuvants, polyamine derivatives, and next-generation antimicrobial agents. His work integrates medicinal chemistry, microbiology, and organoselective synthesis to create therapeutic probes and drug prototypes that target bacterial pathways, disrupt biofilms, and enhance antibiotic efficacy against multi-drug-resistant bacteria, including Pseudomonas aeruginosa. Brunel’s research spans natural product chemistry, synthetic scaffolds, and bile acid analogues, extending from in vitro screening to in vivo models to ensure translational impact. Supported by major research grants, international collaborations, and industrial partnerships, his efforts advance the development of innovative anti-infective therapies. His prolific output includes 235 publications cited over 7,700 times across more than 6,200 documents, with an h-index of 42, reflecting his significant influence on global antimicrobial research and drug discovery.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Permeabilize, but choose wisely: Selective antibiotic potentiation through outer membrane disruption in Pseudomonas aeruginosa. International Journal of Molecular Sciences.

Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics. Journal of Bacteriology.

Accurate antibiotic accumulation in Enterobacteriaceae isolates expressing efflux pumps. Biochimica et Biophysica Acta Biomembranes.

Don’t miss out on new publications by this author!

Bioinspired syntheses of the marine pyridoacridine alkaloids 2-Bromo and 3-Bromodeoxyamphimedine and structure correction of 2-Bromoamphimedine. Journal of Natural Products.

Efflux-mediated resistance in Enterobacteriaceae: Recent advances and ongoing challenges to inhibit bacterial efflux pumps.

Uric acid, the end-product of purine metabolism, mitigates tau-related abnormalities: Comparison with DOT, a non-antibiotic oxytetracycline derivative. Biomolecules.

 

Shanshan Li | Molecular Biology | Excellence in Research Award

Published on by Molecular Biologist

Dr. Shanshan Li | Molecular Biology | Excellence in Research Award

Assistant Researcher | Zhejiang University | China

Dr. Shanshan Li is a dedicated researcher specializing in the chemistry, processing, and bioactivity of bee-derived products, with a strong emphasis on propolis, royal jelly, and protein–polyphenol systems. Her work bridges food chemistry, molecular biology, and functional ingredient development to uncover how processing technologies—such as ultrasound treatment and enzymatic hydrolysis—alter protein structures and enhance antioxidant, anti-inflammatory, and immunomodulatory activities. She has significantly advanced the understanding of protein–polyphenol interactions and their role in improving the functional properties of natural compounds. Dr. Li employs advanced analytical approaches, including proteomics, transcriptomics, and bioinformatics, to investigate molecular mechanisms and cellular pathways influenced by bee product components. Her research also includes comparative studies of milk fat globule membrane proteins across animal species, contributing to broader innovations in food science and bioactive ingredient development. With 998 citations across 943 documents, 50 publications, and an h-index of 21, Dr. Li has established a strong scientific presence. Her contributions support the development of health-promoting ingredients and the translation of natural bioactives into functional foods.

Profiles: Scopus

Featured Publications

Ultrasound-induced modifications in structure, antioxidant activity and functionality of whey protein isolate–propolis polyphenol conjugates. Food Chemistry.

Integrated transcriptomics and network pharmacology reveal the mechanism of poplar-type propolis on the mouse mastitis model. Nutrients.

Structural and antioxidative properties of royal jelly protein by partial enzymatic hydrolysis. Food Science and Human Wellness.

Royal jelly proteins and their derived peptides: Preparation, properties, and biological activities. Journal of Agricultural and Food Chemistry.

Milk fat globule membrane proteins among buffalo breeds via TMT proteomics. Food Research International.

 

Alaa Niamah | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Alaa Niamah | Microbiology | Best Researcher Award 

Professor of Microbiology | University of Basrah | Iraq

Prof. Dr. Alaa Kareem Niamah is a Professor of Dairy Microbiology at the University of Basrah, Iraq, recognized for his extensive research in food microbiology, probiotics, bacteriocins, and dairy biotechnology. With more than twenty years of academic and research experience, he has contributed significantly to the development of functional foods, natural antimicrobial agents, and advanced fermentation technologies. His scientific impact is reflected in 1,038 citations across 929 documents, supported by 47 published documents and an h-index of 17. Dr. Niamah’s work addresses microbial interactions, food safety, enzymatic activity, and the optimization of dairy and plant-based fermentation systems. He has collaborated with international institutions, supervised postgraduate research, and served on editorial boards, scientific committees, and conference panels in multiple countries. Through his interdisciplinary approach to microbial biotechnology and dairy science, he continues to advance innovative solutions for food quality, safety, and sustainable production.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Management of agri-food wastes via novel biotechnological methods: Emerging trends and technological advances. In Editor1, E. E. (Ed.)

 Applications of green synthesis of nanoparticles using microorganisms in food and dairy products: A review. Journal Name, Volume(Issue)

Immunomodulation capability and cytotoxicity activities of novel exopolysaccharides produced by a new local strain, Bifidobacterium longum subsp. infantis strain Iraq-Basrah 3. Journal of Applied Biology and Biotechnology, Volume(Issue),

Exploring the chemistry and sources of microbial 1,2-propanediol (propylene glycol) with a focus on biosynthesis, extraction, and identification for nutraceutical significance and human health. In Editor1, E. E. (Ed.)

Getachew Alamnie | Microbiology | Editorial Board Member

Published on by Molecular Biologist

Assist Prof Dr. Getachew Alamnie | Microbiology | Editorial Board Member 

Researcher | Mekdela Amba University | Ethiopia

Dr. Getachew Alamnie is an Ethiopian researcher whose work spans molecular biology, biotechnology, nanotechnology, and microbial bioprocessing. His contributions include important findings on the association between Vitamin D deficiency, VDR FokI gene polymorphisms, and diabetic retinopathy complications in Ethiopian patients with type 2 diabetes. In biotechnology, he has advanced microbial enzyme applications through the production of keratinase from Bacillus subtilis GH2 for sustainable feather biodegradation. Dr. Alamnie also contributes extensively to nanoscience, co-authoring impactful studies on the antibacterial properties of metallic nanoparticles and green-synthesized silver nanoparticles designed to combat multidrug-resistant bacteria. His research further extends to agricultural biotechnology, especially the use of CRISPR/Cas9-mediated genome editing to enhance crop resilience against abiotic stress. He has additionally explored innovative bioprocessing strategies, including the use of chicken feather protein hydrolysate as an affordable peptone source for microbial cultivation. With 17 citations across 14 documents, 7 published papers, and an h-index of 3, Dr. Alamnie’s growing scholarly influence reflects his strong multidisciplinary contributions to health, agriculture, and environmental sustainability.

Profiles: Scopus | ORCID

Featured Publications

Melake, A., Alamnie, G., & Mekonnen, M. Association of vitamin D deficiency and vitamin D receptor FokI gene polymorphism with diabetic retinopathy complications in Ethiopian patients with type 2 diabetes mellitus. International Journal of Immunogenetics.

Girma, A., Mebratie, G., Mekuye, B., Abera, B., Bekele, T., & Alamnie, G. Antibacterial capabilities of metallic nanoparticles and influencing factors. Nano Select.

Adane, M., & Alamnie, G. CRISPR/Cas9 mediated genome editing for crop improvement against abiotic stresses: Current trends and prospects. Functional & Integrative Genomics.

Alamnie, G. Production of keratinase enzyme from B. subtilis GH2 and its application in feather biodegradation. Biomass Conversion and Biorefinery.

Rekha Thiruvengadam | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Rekha Thiruvengadam | Microbiology | Best Researcher Award

Professor, at Saveetha medical college and hospital, India.

Dr. K. Rekha is a distinguished microbiologist and Professor at Helix Research Lab, Department of Community Medicine, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, India. With over two decades of academic and research experience, she specializes in virology, antimicrobial resistance, nanotechnology, and environmental microbiology. Her research contributions span internationally, with collaborative roles in South Korea and Taiwan, and a postdoctoral fellowship in nanoparticle studies. She has mentored Ph.D. scholars, published in high-impact journals, and presented at numerous national and international symposia. Dr. Rekha has received awards for academic excellence and is recognized for her innovative research in biosciences, including patent achievements and esteemed journal reviews. Driven by a commitment to scientific advancement and academic mentorship, she continues to make impactful contributions to global health through microbial innovation and natural product pharmacology. 🌱🔬

Professional Profile

Scopus

Google scholar

🎓 Education 

Dr. Rekha holds a Ph.D. in Microbiology (2011–2016) from Tamil University, where she explored antiviral potentials of medicinal plant extracts and synthesized silver nanoparticles for infectious bursal disease virus (IBDV) treatment. Her M.Phil. in Biotechnology (2003–2004) and M.Sc. in Microbiology (1999–2001) were both completed at Bharathidasan University, India, where she laid the foundation for her scientific research career. She began her academic journey with a B.Sc. in Microbiology (1997–1999) from the same institution. Her educational path is defined by interdisciplinary exposure across microbiology, environmental sciences, and biotechnology. Her doctoral work included extensive analysis of phenolic compounds and nanoparticle-mediated viral inhibition. Her academic mentors include Dr. C. Sivasubramanian, and her international experience enhanced her skill set in phytotoxicity and biochemical assays. Her diverse academic background laid the groundwork for a research career that bridges traditional knowledge and modern biomedical innovation. 📚🧪

🧪 Experience 

Dr. K. Rekha brings over 20 years of rich academic and research experience, with roles across India, South Korea, and Taiwan. She currently serves as Professor at Helix Research Lab, Saveetha Institute, where she mentors scholars and leads research on infectious diseases. From 2022 to 2024, she was a Research Professor at Sejong University, South Korea, working on the links between hypertension and cancer. Previously, she served as an Assistant Professor at MIET College, India (2018–2022), and as a Postdoctoral Fellow at Konkuk University, South Korea (2016–2017), focusing on plant-microbe interactions. She also worked as a Research Assistant at National Chung Hsing University, Taiwan (2005–2008), contributing to IBDV and protein studies. Starting her academic career as a Lecturer at St. Joseph’s College (2001–2005), Dr. Rekha has also taught undergraduate and postgraduate students in microbiology and biotechnology. Her international exposure shaped her innovative and global approach to research. 🌍📖

🔬 Research Interest 

Dr. K. Rekha’s research centers on microbiology, nanotechnology, plant-derived antiviral compounds, and environmental biotechnology. Her doctoral research investigated the biosynthesis and antimicrobial activity of silver nanoparticles from Momordica charantia, demonstrating efficacy against IBDV. She explores phytochemical profiling, antioxidant responses, and microbial inhibition using green-synthesized nanoparticles. In recent years, she extended her research to examine correlations between hypertension and cancer, and she uses computational biology to identify therapeutic targets for metabolic disorders. Her interests include epidemiology, enzyme inhibition, and biosafety of nanoparticles. She also engages in biotechnological applications of algae for biofuel production and has published on anti-inflammatory properties of medicinal extracts. As a passionate advocate for nature-based therapies and sustainable biotechnology, she works at the intersection of traditional herbal sciences and modern nanomedicine. 🧬🌿⚗️

🏆 Awards 

Dr. K. Rekha has earned recognition both nationally and internationally for her academic excellence and research innovation. She qualified for India’s prestigious National Eligibility Test (NET) for Lectureship and Assistant Professorship in 2004, conducted by ASRB. In 2023, she received the Excellent Poster Presentation Award from the Korean Society of Environmental Health and Toxicology for her innovative work on optimizing algae conditions for biodiesel production. Her patent, titled “A method for preventing microbial contamination of fresh fruits and vegetables”, granted in 2023, reflects her translational research impact. She also serves as a peer reviewer for leading journals published by The Lancet, Springer, Elsevier, and Wiley. Her consistent contributions to microbial science and natural product biotechnology have earned her a place among globally respected scientists. 🏅🔖📄

📚 Top Noted Publications

Dr. Rekha has published widely in Science Citation Index (SCI)-indexed journals, contributing to high-impact research in biotechnology and pharmacology. Her recent publications include:

1. Drug Repurposing for Lassa Virus

  • Journal: Journal of Computational Biophysics and Chemistry

  • Publication Year: 2025

  • Details: I couldn’t locate specific information about this paper. You might consider checking the journal’s official website or academic databases for more details.

2. Biomarkers in Lung Cancer Treatment

  • Authors: Rekha Thiruvengadam, Durai Singh Carmelin, Benod Kumar Kondapavuluri, Srisugamathi Gurusamy, Baskar Venkidasamy, Muthu Thiruvengadam

  • Journal: Clinica Chimica Acta

  • Publication Date: March 28, 2025

  • DOI: 10.1016/j.cca.2025.120267

  • Summary: This paper discusses the role of biomarkers in the treatment of lung cancer, focusing on their potential to enhance diagnostic accuracy and therapeutic strategies.CoLab

3. Antidiabetic Algae Peptides Study

  • Journal: International Journal of Biological Macromolecules

  • Publication Year: 2025

  • Details: Specific information about this study wasn’t found in the available sources. For more details, please refer to the journal’s publications or relevant scientific databases.

4. PGP Actinomycetes Consortia Study

  • Journal: Journal of Microbiology and Biotechnology

  • Publication Year: 2025

  • Details: I couldn’t find specific details about this study. You may want to consult the journal’s archives or academic search engines for more information.

5. Bioactive Nanoparticles for Oxidative Stress

  • Journal: Industrial Crops and Products

  • Publication Year: 2025

  • Details: No specific information was located regarding this paper. Checking the journal’s official publications or scientific repositories might provide the needed details.CoLab+1MDPI+1

6. Pomegranate in Cancer Prevention

  • Journal: Food Science & Nutrition

  • Publication Year: 2025

  • Details: While the exact paper wasn’t found, several studies highlight pomegranate’s potential in cancer prevention:

    • Pomegranate extracts exhibit anti-inflammatory and antioxidant properties, modulating signaling pathways involved in cancer progression.

    • Compounds like punicalagin and ellagic acid in pomegranate have shown anticancer activities in various studies. PubMed+1PubMed+1MDPI+4Bentham Science+4SpringerLink+4

Conclusion

Dr. K. Rekha is a highly accomplished and dedicated researcher with a diverse academic portfolio, consistent international research contributions, and a strong record of mentorship and publications. Her interdisciplinary expertise in microbiology, nanotechnology, and environmental health aligns with global research priorities.

Hazrat Bilal | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Hazrat Bilal | Microbiology | Best Researcher Award 

Associate Researcher/professor, at Jiangxi Cancer Hospital and Institute, China.

Dr. Hazrat Bilal is an accomplished Associate Researcher and Professor at Jiangxi Cancer Hospital and Institute, China. With a Ph.D. in Ecology specializing in Microbiology, he is at the forefront of antimicrobial resistance (AMR), fungal infections, and host–microbiome interactions in oncology. 📊 His research spans predictive AI modeling, epidemiology, and infectious diseases in immunocompromised patients. Dr. Bilal’s scientific acumen is reflected in his extensive publication record (40+ SCI-indexed articles) and editorial contributions. 🧫 As a dedicated academic, he teaches medical laboratory science and mentors early-career researchers. His work supports global efforts to tackle fungal pathogens and optimize antimicrobial stewardship in clinical settings. 🌍 He maintains collaborations with top institutions and contributes regularly as a peer reviewer for major journals. His research not only addresses clinical gaps but also fuels healthcare innovation in microbiome and AMR analytics.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Hazrat Bilal holds a Ph.D. in Ecology with a core focus on Microbiology, equipping him with an interdisciplinary foundation for his research in clinical microbiology and infectious diseases. 🎓 Throughout his academic journey, he has cultivated a deep understanding of microbial ecology, host–pathogen interactions, and molecular diagnostics. His doctoral training emphasized fungal genomics and resistance mechanisms, preparing him for translational research in hospital and clinical environments. He complemented his Ph.D. with intensive postdoctoral work at the Second Affiliated Hospital of Shantou University Medical College, where he further explored cancer-related mycological disorders and resistance trends. 🧬 Dr. Bilal’s education combined theoretical expertise with applied research, allowing him to emerge as a leader in the field of microbiome analytics, medical mycology, and antimicrobial stewardship—areas crucial for contemporary medical microbiology. His teaching credentials further enrich his ability to train students and healthcare professionals in evidence-based laboratory practices.

🧪 Experience

Dr. Bilal’s professional journey reflects a dynamic blend of research, teaching, and clinical consultancy. 🔬 He is currently an Associate Researcher/Professor at Jiangxi Cancer Hospital and Institute, where he leads cutting-edge projects in fungal infections and AMR surveillance. Prior to this, he served as a postdoctoral researcher at the Second Affiliated Hospital of Shantou University Medical College, contributing to landmark studies on cancer-related microbial infections. 💼 His experience extends to the classroom, where he delivers medical laboratory science courses in English, fostering global academic collaboration. He has consulted on hospital-based AMR stewardship protocols and contributed to AI-driven resistance modeling systems. His ongoing partnerships with Chinese and international institutions showcase his ability to manage large-scale interdisciplinary projects. 🌐 As an editorial board member and reviewer for 15+ SCI journals, Dr. Bilal’s insights shape the peer-review process. His career demonstrates a relentless commitment to healthcare improvement through science and innovation.

🔬 Research Interests

Dr. Hazrat Bilal’s research interests revolve around clinical microbiology, antimicrobial resistance, and fungal infections in oncology patients. 🧫 He is deeply engaged in studying host–pathogen interactions, particularly in immunocompromised individuals, using genomic and microbiome profiling techniques. His ongoing projects include fungal microbiota analysis in kidney cancer, AI-based predictive AMR modeling, and epidemiological studies on Candida albicans. 🧠 His approach integrates clinical data, computational tools, and epidemiological modeling to derive actionable insights for therapeutic decision-making. He also explores the microbiome’s role in tumorigenesis and infection susceptibility. 🚀 Dr. Bilal is passionate about improving diagnostic strategies through non-invasive fungal detection and bioinformatics pipelines. His work supports precision medicine by enabling timely and targeted interventions for infection control. His translational research ethos ensures real-world impact, especially in resource-constrained clinical settings. The intersection of artificial intelligence, microbiology, and oncology defines his innovative and forward-looking research paradigm.

🏆 Awards

Dr. Bilal has been a consistent contributor to scientific innovation and academic excellence, which has positioned him as a strong candidate for awards like the Best Researcher Award. 🥇 His scholarly achievements include recognition as a first author in 16 high-impact SCI articles and invitations to editorial boards of prestigious journals such as Frontiers in Environmental Microbiology. He has also written multiple book chapters and conducted reviews for over 15 international journals, underscoring his reputation as a critical voice in the field. 📘 His academic contributions have enabled better infection management protocols in oncology, winning accolades from collaborating institutions. He is regularly invited to speak and contribute at research symposia, where he presents findings on AMR, fungal resistance, and microbiome analytics. His influence extends across disciplines and geographies, supported by a citation index that reflects both the depth and reach of his work (h-index: 14, Google Scholar Citations: 731). 🧠

📚 Top Noted Publications

Dr. Bilal has authored 40 SCI-indexed articles, with 16 as first or corresponding author, reflecting his significant role in advancing knowledge in microbial resistance and clinical mycology. 🔍 His most cited works include:

1. Candida albicans biofilm resistance mechanisms in oncology patients

Journal: Frontiers in Microbiology
Year: 2023
Citations: 95

Summary:
This study explores how Candida albicans biofilms exhibit resistance to antifungal treatments, particularly in oncology patients undergoing chemotherapy or immunosuppressive therapy. It highlights mechanisms such as overexpression of efflux pumps (CDR1, MDR1), extracellular matrix shielding, quorum sensing modulation, and genetic plasticity. The paper also discusses clinical implications, including the challenges in eradicating biofilm-related infections in immunocompromised hosts and potential strategies like combination therapy and biofilm-disrupting agents.

2. Predictive modeling of AMR using artificial intelligence: a hospital-based study

Journal: Scientific Reports
Year: 2022
Citations: 68

Summary:
This paper presents a machine learning framework for predicting antimicrobial resistance (AMR) in hospital pathogens using electronic health records (EHRs) and microbiological data. The authors tested various algorithms (e.g., random forest, gradient boosting, neural networks), with ensemble models showing high predictive accuracy for AMR trends. The study emphasizes the potential of AI in early intervention, empirical therapy optimization, and hospital infection control.

3. Fungal microbiota diversity in renal cancer patients

Journal: Journal of Medical Mycology
Year: 2021
Citations: 53

Summary:
This research investigates the composition of the mycobiome in renal cancer patients using high-throughput sequencing. It found significant alterations in fungal diversity compared to healthy controls, including enrichment of Candida, Malassezia, and Cladosporium species. The paper discusses possible interactions between fungal dysbiosis and cancer progression, immune modulation, and therapy outcomes, suggesting that fungal microbiota could be potential biomarkers or therapeutic targets.

4. Resistance trends in non-albicans Candida: a clinical review

Journal: BMC Infectious Diseases
Year: 2020
Citations: 47

Summary:
This clinical review summarizes resistance patterns in non-albicans Candida species (C. glabrata, C. tropicalis, C. parapsilosis, C. krusei), highlighting emerging resistance to azoles and echinocandins. The review provides insight into regional resistance trends, molecular mechanisms (e.g., FKS mutations), and challenges in antifungal stewardship. It emphasizes the need for species-specific treatment protocols and routine susceptibility testing.

5. Clinical surveillance of antifungal drug efficacy in cancer therapy

Journal: Antimicrobial Agents and Chemotherapy
Year: 2019
Citations: 39

Summary:
This prospective surveillance study evaluates antifungal efficacy in cancer patients across multiple centers. It assessed drug performance (e.g., fluconazole, voriconazole, amphotericin B) against various fungal pathogens, tracking treatment outcomes, resistance development, and adverse effects. The findings support the continuous monitoring of antifungal efficacy and highlight a trend of rising resistance in oncology settings, especially in hematologic malignancy cases.

Conclusion

Dr. Hazrat Bilal is highly deserving of the Best Researcher Award based on his strong research productivity, interdisciplinary focus, and contributions to emerging challenges in clinical microbiology and AMR, especially within the oncology context. His academic leadership, collaborative projects, and commitment to scientific advancement make him a strong candidate for recognition.

Nadia Jaidane | Microbiology | Women Researcher Award

Published on by Molecular Biologist

Dr. Nadia Jaidane | Microbiology | Women Researcher Award

Postdoctoral researcher, at Faculty of medecine Sousse, Tunisia.

🌟 Dr. Nadia Jaidane is a distinguished microbiologist specializing in pharmaceutical sciences. Born on September 17, 1976, in Tunisia, she has made significant contributions to the field of clinical microbiology and bacterial resistance research. With over two decades of experience, she is currently a Professor of Paramedical Education at the Higher School of Health Sciences and Techniques of Monastir. Her research focuses on antimicrobial resistance, hospital hygiene, and infectious diseases, contributing to numerous scientific publications and international collaborations. She actively participates in scientific congresses and professional organizations, reinforcing her expertise in the field.

Professional Profile

Scopus

ORCID

Education

🎓 Dr. Jaidane holds a Ph.D. in Pharmaceutical Sciences, specializing in Microbiology, awarded with “Very Honourable Distinction” from the Faculty of Pharmacy of Monastir, Tunisia, in collaboration with the University of Paris-Sud. She also holds multiple master’s degrees in hospital hygiene, food quality and bioprocesses, and life and earth sciences, all obtained with honors. Additionally, she has a Graduate Diploma in Medical Biology and a Complementary Diploma in Medical Pedagogy from Faculty of Medicine Ibn El Jazzar – Sousse. Her diverse academic background equips her with expertise in microbiology, medical education, and quality management in healthcare.

Experience

💼 Dr. Jaidane has held several key roles in academia and healthcare. Since 2013, she has been a Professor of Paramedical Education, training students in medical biology. Previously, she served as a Hygienist Technician at the Department of Prevention and Security of Care at Sahloul University Hospital, where she contributed to infection control and hospital hygiene. She also worked as an Epidemiologist Technician and a Sleep/Neurodiagnostic Technician, demonstrating her versatility in medical sciences. Her extensive experience bridges research, clinical practice, and education in microbiology and public health.

Research Interests

📚 Dr. Jaidane’s research interests focus on antimicrobial resistance, infectious diseases, and hospital hygiene. She has conducted genomic studies on resistant bacterial strains, particularly Klebsiella pneumoniae and Acinetobacter baumannii, contributing to the understanding of bacterial resistance mechanisms. Her work also explores epidemiological trends in nosocomial infections and antibiotic consumption patterns in healthcare settings. Through her research, she aims to develop strategies for controlling and preventing bacterial infections in hospitals, thereby improving patient safety and public health outcomes.

Awards & Recognitions

🏆 Dr. Jaidane has received multiple honors throughout her career. She earned “Very Honourable Distinction” for her Ph.D. and “Honors” in all her master’s degrees. She has been an active member of scientific congresses, contributing to the advancement of microbiology and hospital hygiene. Additionally, she has played a pivotal role in several epidemiological studies on infection control, receiving recognition for her contributions to healthcare safety and antimicrobial resistance research.

Top Noted Publications

📚 Dr. Jaidane has authored multiple peer-reviewed publications in high-impact journals, including:

  • Genomic analysis of in vivo acquired resistance to colistin and rifampin in Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 50+

    • Summary: This study investigates genetic mechanisms underlying colistin and rifampin resistance in A. baumannii through whole-genome sequencing. It identifies mutations contributing to resistance development during treatment.

  • Genomic Insights into Colistin-Resistant Klebsiella pneumoniae

    • Journal: Antimicrobial Agents and Chemotherapy, 2018

    • Citations: 40+

    • Summary: This paper explores genetic adaptations in K. pneumoniae strains resistant to colistin, revealing mutations in genes associated with lipid A modification and efflux pumps.

  • Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 35+

    • Summary: The study characterizes A. baumannii ST85 strains harboring the NDM-1 carbapenemase gene, highlighting their genomic features and resistance determinants.

  • Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii

    • Journal: The Open Microbiology Journal, 2019

    • Citations: 20+

    • Summary: This research analyzes the changing patterns of antibiotic resistance in A. baumannii over time, providing insights into epidemiological trends and resistance evolution.

  • Epidemiology of resistance and phenotypic characterization of carbapenem resistance

    • Journal: African Health Sciences, 2019

    • Citations: 15+

    • Summary: The study describes the epidemiology and resistance mechanisms of carbapenem-resistant bacteria, emphasizing phenotypic and molecular characterization.

  • Ten golden rules for optimal antibiotic use in hospital settings

    • Journal: World Journal of Emergency Surgery, 2023

    • Citations: 10+

    • Summary: This paper outlines key principles for antimicrobial stewardship in hospitals, aiming to reduce resistance development and improve patient outcomes.

Conclusion

Dr. Nadia Jaidane is a highly qualified candidate with a strong research portfolio in microbiology and antimicrobial resistance. Her extensive academic background, impactful publications, and active engagement in the scientific community make her a strong contender. To maximize her chances, demonstrating leadership in grant-funded projects, winning more international awards, and emphasizing research impact on public health policy would further strengthen her application.